NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Net Sales | ₹365 Cr | ₹333 Cr | ₹301 Cr | ₹278 Cr | ₹138 Cr |
What is the latest Revenue of NATH BIOGENES (INDIA) ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹365 Cr |
| Mar2024 | ₹333 Cr |
| Mar2023 | ₹301 Cr |
| Mar2022 | ₹278 Cr |
| Mar2013 | ₹138 Cr |
How is Revenue of NATH BIOGENES (INDIA) Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹365 Cr | 9.71 | |
| Mar2024 | ₹333 Cr | 10.37 | |
| Mar2023 | ₹301 Cr | 8.26 | |
| Mar2022 | ₹278 Cr | 102.15 | |
| Mar2013 | ₹138 Cr | - | |
Compare Revenue of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹301.3 Cr | -3.8% | -3.4% | -15.4% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,999.1 Cr | -6% | -14.1% | -28.9% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,200.2 Cr | 0.2% | 5% | -3.8% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,078.2 Cr | 1.6% | 1% | -6% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹900.5 Cr | 0.1% | 0.8% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹510.5 Cr | -3% | -3.9% | -8% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -3.8% |
-3.4% |
-15.4% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses